RU2007105141A - APPLICATION OF CYCLOSPORINS FOR TREATMENT OF ALZHEIMER'S DISEASE - Google Patents
APPLICATION OF CYCLOSPORINS FOR TREATMENT OF ALZHEIMER'S DISEASE Download PDFInfo
- Publication number
- RU2007105141A RU2007105141A RU2007105141/15A RU2007105141A RU2007105141A RU 2007105141 A RU2007105141 A RU 2007105141A RU 2007105141/15 A RU2007105141/15 A RU 2007105141/15A RU 2007105141 A RU2007105141 A RU 2007105141A RU 2007105141 A RU2007105141 A RU 2007105141A
- Authority
- RU
- Russia
- Prior art keywords
- cyclosporin
- meleu
- hydroxy
- val
- cyclophilin
- Prior art date
Links
- NXAUWPUGVYNWGZ-UHFFFAOYSA-N CN(C)C1C=C1 Chemical compound CN(C)C1C=C1 NXAUWPUGVYNWGZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58777004P | 2004-07-13 | 2004-07-13 | |
US60/587,770 | 2004-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007105141A true RU2007105141A (en) | 2008-08-20 |
Family
ID=35276396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007105141/15A RU2007105141A (en) | 2004-07-13 | 2005-07-12 | APPLICATION OF CYCLOSPORINS FOR TREATMENT OF ALZHEIMER'S DISEASE |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1893226A1 (en) |
JP (1) | JP2008512351A (en) |
KR (1) | KR20070036127A (en) |
CN (1) | CN1984670A (en) |
AU (2) | AU2005261838A1 (en) |
BR (1) | BRPI0513317A (en) |
CA (1) | CA2573400A1 (en) |
MX (1) | MX2007000502A (en) |
RU (1) | RU2007105141A (en) |
WO (1) | WO2006005580A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1931696B1 (en) | 2005-09-30 | 2011-02-16 | Scynexis, Inc. | Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
US7696166B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
US7696165B2 (en) | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
DE602007013391D1 (en) | 2006-05-19 | 2011-05-05 | Scynexis Inc | CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF EYE DISEASES |
FR2913886B1 (en) | 2007-03-22 | 2012-03-02 | Guerbet Sa | USE OF METAL NANOPARTICLES IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE |
US20100291074A1 (en) * | 2007-07-27 | 2010-11-18 | Columbia University In The City Of New York | Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease |
CN102083852A (en) * | 2008-06-06 | 2011-06-01 | 西尼克斯公司 | Cyclosporin analogs and their use in the treatment of HCV infections |
WO2009148615A1 (en) * | 2008-06-06 | 2009-12-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
CA2748389A1 (en) | 2008-12-31 | 2010-07-08 | Scynexis, Inc. | Derivatives of cyclosporin a |
EP2509615A1 (en) * | 2009-12-09 | 2012-10-17 | Scynexis, Inc. | Novel cyclic peptides |
KR20120035622A (en) * | 2010-10-06 | 2012-04-16 | 서울대학교산학협력단 | Method for curing parkinson's disease through regulating vdac1 protein |
CN102586121B (en) * | 2012-02-21 | 2013-07-10 | 淮海工学院 | Fungus producing acetylcholinesterase inhibitor, and its application |
WO2014049540A2 (en) | 2012-09-29 | 2014-04-03 | Novartis Ag | Cyclic peptides and use as medicines |
EP2908841A4 (en) * | 2012-10-19 | 2016-05-25 | Scynexis Inc | New antiviral macrocycles |
CN106620648A (en) * | 2016-12-30 | 2017-05-10 | 山东景源生物科技有限公司 | Medicine for blocking lymphocyte cell cycle of patients with Parkinson's disease and preparation method of medicine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0484281T4 (en) * | 1990-11-02 | 2001-02-05 | Novartis Ag | cyclosporines |
JP3089350B2 (en) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | Inhibitors of cyclophilin rotamase activity |
US20030103959A1 (en) * | 2001-06-22 | 2003-06-05 | Hughes Paul E. | Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor |
-
2005
- 2005-07-12 RU RU2007105141/15A patent/RU2007105141A/en not_active Application Discontinuation
- 2005-07-12 BR BRPI0513317-3A patent/BRPI0513317A/en not_active IP Right Cessation
- 2005-07-12 CN CNA2005800237213A patent/CN1984670A/en active Pending
- 2005-07-12 EP EP05774275A patent/EP1893226A1/en not_active Withdrawn
- 2005-07-12 WO PCT/EP2005/007556 patent/WO2006005580A1/en active Application Filing
- 2005-07-12 AU AU2005261838A patent/AU2005261838A1/en not_active Abandoned
- 2005-07-12 CA CA002573400A patent/CA2573400A1/en not_active Abandoned
- 2005-07-12 KR KR1020077000882A patent/KR20070036127A/en not_active Application Discontinuation
- 2005-07-12 JP JP2007520737A patent/JP2008512351A/en active Pending
- 2005-07-12 MX MX2007000502A patent/MX2007000502A/en not_active Application Discontinuation
-
2009
- 2009-08-17 AU AU2009210375A patent/AU2009210375A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0513317A (en) | 2008-05-06 |
AU2005261838A1 (en) | 2006-01-19 |
CA2573400A1 (en) | 2006-01-19 |
EP1893226A1 (en) | 2008-03-05 |
CN1984670A (en) | 2007-06-20 |
KR20070036127A (en) | 2007-04-02 |
AU2009210375A1 (en) | 2009-09-10 |
WO2006005580A1 (en) | 2006-01-19 |
MX2007000502A (en) | 2007-03-08 |
JP2008512351A (en) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007105141A (en) | APPLICATION OF CYCLOSPORINS FOR TREATMENT OF ALZHEIMER'S DISEASE | |
JP2008512351A5 (en) | ||
RU2006110533A (en) | APPLICATION OF MODIFIED CYCLOSPORINES FOR THE TREATMENT OF DISEASES CAUSED BY HCV | |
JP4350898B2 (en) | Novel cyclosporine with improved activity characteristics | |
AU2011316690B2 (en) | Cyclosporin analogs | |
ES2258282T3 (en) | FIBROSIS INHIBITION PROCEDURE WITH SOMATOSTATIN AGONISTS. | |
AU2013267435B2 (en) | Cyclosporin A analogs | |
AU2017267560B2 (en) | Novel cyclosporin derivatives and uses thereof | |
US8367053B2 (en) | Cyclosporin analogues | |
ES2718499T3 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
JP2008535841A5 (en) | ||
US9890198B2 (en) | Cyclosporin derivatives and uses thereof | |
CA2730108A1 (en) | Cyclosporin derivatives for treating ocular and dermal diseases and conditions | |
JP2010059177A (en) | Use of cyclosporins in treatment of inflammatory autoimmune disease | |
RU2007128098A (en) | COMPOUNDS FOR TREATING INFECTIONS CAUSED BY VIRUSES OF THE FLAVIVIRIDAE FAMILY | |
RU2009117699A (en) | APPLICATION OF MODIFIED CYCLOSPORINS | |
EP2968445A2 (en) | Novel cyclosporin derivatives and uses thereof | |
JP2002516873A5 (en) | ||
RU2003133742A (en) | MODIFIED CYCLOSPORIN, WHICH CAN BE USED AS A MEDICINE, AND ITS APPLICATION | |
RU2006139004A (en) | The use of cyclosporins for the treatment of cerebral ischemia and damage to the brain and spinal cord | |
US20150111815A1 (en) | Novel cyclosporin derivatives for the treatment and prevention of viral infections | |
RU2001101153A (en) | APPLICATION OF CYCLOSPORINS FOR THE TREATMENT OF INFLAMMATORY AUTOIMMUNE DISEASES | |
JP2016522178A (en) | Angiotensin in muscular dystrophy | |
JP2017501967A (en) | Novel peptide composition | |
NZ576523A (en) | Use of modified cyclosporins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090311 |